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Should these potential CMR substances have been registered under REACH? 
Background REACH pre-registration substances (PRS) classified for C, 
M or R in category 1 or 2 should have been registered by December 
2010. However, it is well-known that for low tonnage and even for the 
high tonnage EU industrial substances the majority have few or no 
experimental CMR test data /1/. As a result, CMR substances presently 
used in the EU may with high probability not have been REACH 
registered under REACH, and registered substances may not have been 
classified for CMR effects.  
 
Aim The aim was by (Q)SAR to predict potential CMR properties and on 
this basis make overall CMR calls for the following substances:  
 
 
 
 
 
Start lists The initial lists were the ECHA list of registered 
substances as of 15th June 2012 with 5,306 publishable registered 
substances /2/ and the ECHA PRS with 143,835 substances /3/. 
 
Step 1 The applied (Q)SAR models can predict discrete organic 
substances based on structural information (e.g. SMILES). No formal 
structure set exists for the PRS so a list made by the EU JRC was used 
/4/. This list contains structure information for 80,413 substances of 
which 70,983 could be used in the applied (Q)SAR software. 
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Abstract (Q)SAR models were applied to screen around 68,000 REACH pre-registered substances for CMR  properties (carcinogenic, 
mutagenic or toxic to reproduction). Predictions from 14 relevant models were combined to reach overall calls for C, M and R. Combining 
predictions may reduce “noise” and increase accuracy in the overall call. The Nordic substance register database (SPIN) was used to identify 
not registered substances where human exposure is likely to be significant. The Danish EPA may use the results for future priority setting for 
e.g. proposals for (harmonized) CMR-classification or targeted experimental confirmatory testing and potential inclusion on the EU CORAP list. 
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Step 2 Substances with EU harmonized classifications were removed 
by CAS number comparison, where possible also for group entries.  
 
Step 3 Substances with at least one CMR R-phrase (R40, R45, R46, 
R49, R60, R61, R62, R63, R64 or R68) in the REACH registration 
dossiers were filtered out.  
 
Step 4 (Q)SAR predictions were generated in 14 models in the 
MultiCASE MC4PC software. C-, M- and R-classifications were 
generated according to decision algorithms as done in the Danish 
Advisory Classification list /5/.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Step 5 The Use Index for consumers in the Nordic substance register 
database (SPIN) was required to be greater than or equal to 3, 
indicating a potential for direct exposure to humans.  
 
Step 6 To illustrate how the lists may be applied for e.g. priority 
setting for proposals for (harmonized) CMR-classification and/or for 
inclusion on the CORAP list (by targeted further confirmatory testing 
of CMR properties), a number of substances were further inspected 
manually consulting also other sources of (Q)SAR predictions and 
experimental information where available.  
 
Results The results will be used by the Danish EPA in future priority 
setting, and the lists and a documentation report is scheduled to be 
published this year on their website www.mst.dk. 
Models applied The models are validated with established accuracies 
of 70-85% and generally having considerably higher specificity than 
sensitivity: 
•Models for in vitro: • Reverse mutation test (Ames) • Chromosomal 
aberrations (CA) in CHO • Chromosomal aberration (CA) in CHL • 
Mouse lymphoma cell gene mutation test. 
•Models for in vivo: • Drosophila melanogaster Sex-Linked Recessive 
Lethal test • Comet assay in mouse • Sister chromatid exchange assay 
in mouse bone marrow • Rodent dominant lethal test • Mouse 
mammalian bone marrow erythrocyte micronucleus test • 4 FDA Cancer 
models for M/F Rat and Mouse plus overall cancer call• Teratogenic 
risk in humans. 
 
• Registered substances that are not self-classified by industry as C                      
and/or M and/or R 
• Not registered PRS possibly due to unrecognized CMR properties  / 
lack of test data. 
EUROTOX 2013 Interlaken , Switzerland 
Example CAS RN 3454-29-3 with (Q)SAR calls  
C, M and R based on positive predictions in models  
for Ames, CA CHO, CA CHL, mouse lymphoma,  
Drosophila m. SLRL, mouse Comet, and FDA overall  
cancer call based on male mouse and female mouse.  
Used in epoxy resins. No CMR relevant experimental information was  
identified. In SPIN, one or several uses indicate a potential exposure 
to consumers and a very probable exposure to workers, and 1.1 tonnes 
in Sweden and 1 tonne in Norway. 155 notifiers in ECHA C&L Inventory 
with no self-classifications for CMR. 
 
  
 
Not registered 
substances 
143,835 
69,438 
67,656 
Registered 
substances 
5,306 
1,545 
1,066 
Start lists 
Step 1 
Selection of substances for QSAR screening  
  
Step 2 
Removal of substances with EU classification 
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Step 4 
Selection of CMR predicted substances 
  
Step 5 
SPIN filter 
  
Step 6 
Manual selection of cases for illustration 
  
Step 3 
CMR class. filter 
  
